A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosis
Sign Up to like & getrecommendations! Published in 2020 at "Translational Psychiatry"
DOI: 10.1038/s41398-020-01095-8
Abstract: NMDA autoantibody encephalitis presenting as schizophrenia suggests the possible role of adaptive cell-mediated immunity in idiopathic schizophrenia. However, to our knowledge there have been no trials of the immune-suppressant methotrexate in schizophrenia. We tested if… read more here.
Keywords: randomised clinical; trial methotrexate; clinical trial; points possible ... See more keywords